PEGylation of E1-Deleted Adenovirus Vectors Allows Significant Gene Expression on Readministration to Liver
The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Systemic administration of adenoviral vectors leads to activation of innate and antigen-specific immunity. In an attempt to diminish T and B cell-specific immune responses to E1-deleted adenoviral vectors, capsid proteins were modified with various activated monomethoxypolyethylene glycols (MPEGs). The impact of this modification was studied in a murine model of liver-directed gene transfer in which an E1-deleted adenovirus expressing the lacZ gene was given intravenously. The efficiency of vector transduction of hepatocytes in vivo was not compromised by any of the polymer chemistries. PEGylation of the virus, however, diminished the activation of cytotoxic T lymphocytes and helper T cells of the type 1 subset (Th1 cells) against native viral antigens; neutralizing antibodies to native virus were also diminished. PEGylation prolonged transgene expression and allowed partial readministration with native virus or with a virus PEGylated with a heterologous chemical moiety. Apparently, modification of the capsid leads to a shift in antigenic epitopes because vector readministration was not possible when the immunizing vector had been modified by the same PEGylation chemistry used to modify the second vector. In light of these results, the concept of improving the performance of adenoviral vectors through modification of the capsid with PEG shows promise.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451 · cited 1×
“…vectors expressing either green fluorescent protein or b -galactosidase under the control of cytomegalovirus (CMV) promoters were amplified in 293 cells, using a modification of established methods, and purified from cell lysates by banding twice on CsCl gradients (Graham and van der Eb, 1973).”
Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gönczöl, E., & Wilson, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4407 · Cited by 1,575 · cited 1×
“T cell-dependent, antigen-specific immunity to newly synthesized viral and transgene products limits the duration of gene expression after secondary administration (Yang et al ., 1994b, 1995; Barr et al ., 1995; Yang and Wilson, 1995).”
Self-citationAbuchowski, A., van Es, T., Palczuk, N. C., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40291-2 · Cited by 1,358
Abuchowski, A., McCoy, J. R., Palczuk, N. C., van Es, T., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40292-4 · Cited by 1,274 · cited 1×
“…Abuchowski et al . demonstrated that conjugating primary amino groups of enzymes with polyethylene glycol (PEG) improved therapeutic efficacy, enhanced circulation half-life in vivo , reduced immunogenicity, and enhanced physical stability and in vivo bioactivity (Abuchowski et al ., 1977a,b).”
Yang, Y., Li, Q., Ertl, H. C., & Wilson, J. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2004-2015.1995 · Cited by 1,032 · cited 3×
“It is known that intravenous administration of first-generation adenoviruses elicits significant MHC class I-restricted CTL responses, leading to loss of transgene expression by mechanisms that destroy virus-infected cells (Yang et al ., 1995, 1996a).”
Self-citationThe polypeptides of adenovirus
Maizel, J. V., White, D. O., & Scharff, M. D. (1968) · Virology · doi:10.1016/0042-6822(68)90121-9 · Cited by 884
Immune responses to adenovirus and adeno-associated virus in humans
Chirmule, N., Propert, K. J., Magosin, S. A., Qian, Y., Qian, R., & Wilson, J. M. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300994 · Cited by 684 · cited 1×
“Serum samples from mice were Ad-specific, isotype-specific immunoglobulins (IgG1, IgG2a, IgG2b, and IgG3) by ELISA as described previously (Chirmule et al ., 1999).”
Self-citationConstant, S., Pfeiffer, C., Woodard, A., Pasqualini, T., & Bottomly, K. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1591 · Cited by 677
Schiedner, G., Morral, N., Parks, R. J., Wu, Y., Koopmans, S. C., Langston, C., Graham, F. L., Beaudet, A. L., & Kochanek, S. (1998) · Nature Genetics · doi:10.1038/ng0298-180 · Cited by 648
Yang, Y., Ertl, H. C. J., & Wilson, J. M. (1994) · Immunity · doi:10.1016/1074-7613(94)90074-4 · Cited by 611 · cited 2×
“T cell-dependent, antigen-specific immunity to newly synthesized viral and transgene products limits the duration of gene expression after secondary administration (Yang et al ., 1994b, 1995; Barr et al ., 1995; Yang and Wilson, 1995).”
Self-citation
Cited by
Pre-existing Anti–Adeno-Associated Virus Antibodies as a Challenge in AAV Gene Therapy
Louis Jeune, V., Joergensen, J. A., Hajjar, R. J., & Weber, T. (2013) · Human Gene Therapy Methods · doi:10.1089/hgtb.2012.243 · Cited by 358
“Importantly, PEGylation—that is, the process of attaching PEG—has been used previously to prevent neutralization of adenoviral vectors upon repeated vector administration (O’Riordan et al., 1999; Croyle et al., 2001, 2002).”
Gutless adenovirus: last-generation adenovirus for gene therapy
Alba, R., Bosch, A., & Chillon, M. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302612 · Cited by 303
Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses
Komarova, S., Kawakami, Y., Stoff-Khalili, M. A., Curiel, D. T., & Pereboeva, L. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0334 · Cited by 302
“Two control mice (6, 7) did not receive MPC injections.”
BackgroundImmunity to adenovirus and adeno-associated viral vectors: implications for gene therapy
Jooss, K., & Chirmule, N. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302037 · Cited by 277
Self-citationHartman, Z. C., Appledorn, D. M., & Amalfitano, A. (2008) · Virus Research · doi:10.1016/j.virusres.2007.10.005 · Cited by 239
“Studies have also shown that “PEGylation” results in a reduced uptake of Ad vectors by Kupffer cells and macrophages in vitro (Croyle et al., 2002; Croyle et al., 2005; O'Riordan et al., 1999) These complexities point to future studies required to dissect out and assess the significance of the multi-faceted interactio…”
Background
Metadata
- Authors
- Croyle, M. A., Chirmule, N., Zhang, Y., & Wilson, J. M.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 2002-10-10
- Volume
- 13
- Issue
- 15
- Pages
- 1887-1900
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W1975752974
- Cited by
- 166
- References
- 63
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PEGylation of E1-Deleted Adenovirus Vectors Allows Significant Gene Expression on Readministration to Liver. https://app.cochat.ai/papers/10.1089/104303402760372972
- The paper
- Croyle, M. A., Chirmule, N., Zhang, Y., & Wilson, J. M. (2002). PEGylation of E1-Deleted Adenovirus Vectors Allows Significant Gene Expression on Readministration to Liver. Human Gene Therapy. https://doi.org/10.1089/104303402760372972
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.